Activest Wealth Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.9K Hold
3,000
0.01% 276
2026
Q1
$44.5K Hold
3,000
0.01% 359
2025
Q4
$47.9K Hold
3,000
0.01% 326
2025
Q3
$33.1K Hold
3,000
0.01% 307
2025
Q2
$25.4K Hold
3,000
0.01% 285
2025
Q1
$24.1K Hold
3,000
0.01% 269
2024
Q4
$26.9K Hold
3,000
0.01% 223
2024
Q3
$22K Hold
3,000
0.01% 246
2024
Q2
$17.1K Buy
+3,000
New +$15.8K 0.01% 248

Other funds holding AUPH

Activest Wealth Management's AUPH Position: Q2 2026 in Review

Activest Wealth Management held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 3,000 shares worth $50.9K. The position accounts for 0.01% of the portfolio, ranked #276.

Activest Wealth Management first reported a position in AUPH in Q2 2024 and has held it in 9 quarters since. 59 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Activest Wealth Management held 3,000 shares of Aurinia Pharmaceuticals worth $50.9K as of Q2 2026.
  • Activest Wealth Management left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
  • Aurinia Pharmaceuticals made up 0.01% of Activest Wealth Management's portfolio in Q2 2026, its #276 holding.
  • Activest Wealth Management first reported a position in Aurinia Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 59 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.